Piramal, Pharma

Piramal Pharma Limited Announces Consolidated Results for Q1FY25

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Piramal Pharma Ltd Italy United States of America United Kingdom Canada France Germany Spain India

| LinkedIn

 # EIR - Establishment Inspection Report
* Includes one facility via PPL's minority investment in Yapan Bio.

Logo: https://mma.prnewswire.com/media/1855206/Piramal_Pharma_Limited_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-limited-announces-consolidated-results-for-q1fy25-302207455.html

en | boerse | 67989654 |